IO Biotech, Inc. (IOBTQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Aug 28, 2026

IO Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
06112466184-
Market Cap Growth
-99.99%-51.06%86.88%-64.06%--
Enterprise Value
-13-18-39-82268-
Last Close Price
0.000.921.882.306.40-

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PB Ratio
0.011.290.930.480.87-
P/TBV Ratio
0.011.290.930.480.87-

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
19.890.040.020.02--
Net Debt / Equity Ratio
-13.77-1.24-1.06-1.01-1.00-1.31
Net Debt / EBITDA Ratio
0.140.611.541.965.13-
Net Debt / FCF Ratio
0.160.711.952.315.190.34
Quick Ratio
1.733.149.1813.5020.731.61
Current Ratio
2.013.339.3713.8821.521.85
Return on Equity (ROE)
-240.48%-106.00%-63.29%-40.74%-63.28%-2127.56%
Return on Assets (ROA)
-88.58%-54.47%-37.78%-23.87%-22.61%-84.11%
Return on Capital Employed (ROCE)
-425.30%-197.40%-67.70%-50.60%-19.50%-389.70%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-1227922.17%-157.55%-69.50%-107.82%-36.81%-
FCF Yield
-1126685.20%-135.94%-58.18%-91.16%-22.12%-
Buyback Yield / Dilution
-0.31%-51.31%-51.10%-564.62%-2346.74%-